LOS ANGELES, July 22, 2021 /PRNewswire/ –Valiant Eagle, Inc (OTC Pink: PSRU) is pleased to announce that after a series of extensive negotiations, our subsidiary, Providence Film Group, Inc., has acquired the full rights to 12 famous movies, including remake/reboot rights. The list includes one of Bruce Lee’s most classic movies, “Fists of Fury” as well as Wes Craven’s, “Swamp Thing.”
Complete List of Acquired Movies:
- Adios Amigos (1976):
Adios Amigo is an American comedy-western film written, produced and directed by Fred Williamson, who also stars in the lead role. The film co-stars Richard Pryor and James Brown.
- Adventures of Huckleberry Finn (1953):
A special dramatization for TV of the celebrated ‘Duke and the Dauphin’ scenes from Mark Twain’s Huckleberry Finn.
- Black Brigade, aka Carter’s Army (1970):
Carter’s Army is a 1970 American made-for-television war drama film starring a host of prominent African-American film actors, including Richard Pryor, Rosey Grier, Robert Hooks, Billy Dee Williams and Moses Gunn.
- Bloody Wednesday (1985)
Bloody Wednesday is a 1988 thriller film directed by Mark G. Gilhuis and starring Raymond Elmendorf, Pamela Baker, and Jeff O’Haco. It is based on the events of the San Ysidro McDonald’s massacre.
- Callie and Son (1981):
Callie & Son is a CBS network television movie which aired on October 13, 1981.
After her infant son is stolen from her, teenage mother Callie (Lindsay Wagner) swears that they will be reunited one day. Years later, after marrying a wealthy man (Dabney Coleman), Callie finally succeeds at tracking him down. Now grown, her son Randy (Jameson Parker) is running for office, but when his marriage to a manipulative vixen (Michelle Pfeiffer) jeopardizes his political aspirations and the young woman suddenly ends up dead, Callie must stand by and watch her son’s murder trial.
- Fists of Fury (1971):
The Big Boss (Chinese: 唐山大兄, lit. “The Big Brother from Tangshan”; originally titled Fists of Fury in America) is a 1971 Hong Kong martial arts action film produced by Raymond Chow, and starring Bruce Lee in his first major film. It stars Lee, Maria Yi, James Tien and Tony Liu. Originally written for Tien, the leading role was given to Lee instead when the film’s original director, Ng Kar-seung, was replaced by Lo. The film was a critical success and excelled at the box office. Lee’s strong performance overshadowed Tien, already a star in Hong Kong, and made Bruce Lee famous in Asiaand eventually the world.
- Ginger in the Morning (1974):
Ginger in the Morning is a 1974 comedy-drama film starring Sissy Spacek as a hitchhiker. It was only the third theatrical film for Spacek, and the first American film appearance of Fred Ward.
- Great American Tragedy (1972):A middle-aged aerospace engineer (George Kennedy) has his whole life changed when he is suddenly laid off from his job. Unable to find work because of his age and a bad economy, he watches his bills pile up, his wife (Vera Miles) forced to go back to work and his marriage start to break up
Starring: George Kennedy, Vera Miles, James Woods and William Windom
- Gulliver’s Travels (1939):
Gulliver’s Travels is a 1939 American cel-animated Technicolor musical feature film produced by Max Fleischer and directed by Dave Fleischer for Fleischer Studios. Released to cinemas in the United States on December 22, 1939 by Paramount Pictures, the story is a very loose adaptation of Jonathan Swift’s 1726 novel of the same name, specifically the first part which tells the story of Lilliput and Blefuscu, and centers around an explorer who helps a small kingdom who declared war after an argument over a wedding song. The film was the Fleischer Studios’ first feature-length animated film, as well as the second animated feature film produced by an American studio after Walt Disney Productions’ Snow White and the Seven Dwarfs, as Paramount had commissioned the feature in response to the success of that film. The sequences for the film were directed by Seymour Kneitel, Willard Bowsky, Tom Palmer, Grim Natwick, William Henning, Roland Crandall, Thomas Johnson, Robert Leffingwell, Frank Kelling, Winfield Hoskins, and Orestes Calpini. - Nuclear Run (1980):
The Chain Reaction A.K.A. Nuclear Run is a 1980 Australian science fiction thriller film directed and written by Ian Barry. The film’s plot is about an engineer badly injured in an accident caused by an earthquake. He knows that the nuclear waste will poison the groundwater and wants to warn the public.
- Revenge of Doctor X (1970):
Venus Flytrap (also known as Body of the Prey and The Revenge of Doctor X) is a 1970 American science fiction horror film shot partly in Japan. It was distributed by the Toei Company of Japan. The plot features a mad scientist who uses lightning to turn carnivorous plants into sentient man-eating creatures.
- Swamp Thing (1982):
Swamp Thing is a 1982 American superhero horror film written and directed by Wes Craven, based on the Vertigo/DC Comics character of the same name created by Len Wein and Bernie Wrightson. It tells the story of scientist Alec Holland (Ray Wise) who becomes transformed into the monster the Swamp Thing (Dick Durock) through laboratory sabotage orchestrated by the evil Anton Arcane (Louis Jourdan). Later, he helps a woman named Alice Cable(Adrienne Barbeau) and battles the man responsible for it all, the ruthless Arcane.
Under the terms and conditions of the asset acquisition, Valiant Eagle and its subsidiaries have “all rights of every kind” to distribute, broadcast, and sell anywhere in the world. This includes copyright interests, all production rights, subsidiary rights, and more. Furthermore, Valiant Eagle will retain all negative and positive films, picture prints, and all other forms of media related to the titles above.
Valiant Eagle intends to fully utilize its extensive new cinematic assets to increase shareholder value. Further details will be provided as they become available.
Xavier Mitchell, CEO of both Valiant Eagle Inc. and Providence Film Group Inc., states, “The acquisition of these famous titles with remake rights propels our progress further by years. We expect to get A-List actors to sign on to the remakes while collecting revenues from the original movies. The consideration paid was a king’s ransom but, with regards to Fists of Fury which is better known as The Big Boss, we anticipate a blockbuster in 2022 with a remake. We are equally excited to enter the DC Universe with our acquisition of Swamp Thing.”
About Valiant Eagle, Inc
Valiant Eagle Inc (OTC:PSRU) is a publicly-traded corporation focused on the energizing of celebrity entertainment, social media and TV communications. VE aims to achieve an unparalleled advancement towards media through music, sports and, with respect to the millennial generation, through technology. Technology is an important part of our life especially in the last century more than ever. With benefits such as speed, accuracy, unlimited information and more, the internet has provided various means of communicating without delay nor difficulty. However, a level of consumer satisfaction has yet to be reached. Valiant Eagle, Inc. looks to fill this void.
Legal Notice Regarding Forward-Looking Statements: This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. That includes the possibility that the business outlined in this press release cannot be concluded for some reason. That could be as a result of technical, installation, permitting or other problems that were not anticipated. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Valiant Eagle, Inc. to be materially different from the statements made herein. Except for any obligation under the U.S. federal securities laws, Valiant Eagle, Inc. undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.
Disclosure: Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.
All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated three thousand five hundred dollar by the company for the creation and dissemination of this content by the company.
This material does not represent a solicitation to buy or sell any securities. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management.
The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.
Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/
